4/A//SEC Filing
CPF III PT SPV, LLC 4/A
Accession 0001062993-23-018941
CIK 0001832511other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:18 AM ET
Size
15.8 KB
Accession
0001062993-23-018941
Insider Transaction Report
Form 4/AAmended
Transactions
- Purchase
Class A Common Stock
2023-09-13$2.65/sh+90,000$238,221→ 49,755,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-11$2.34/sh+90,000$210,222→ 49,575,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-12$2.63/sh+90,000$236,520→ 49,665,442 total(indirect: See Footnote)
CPF III-A PT SPV, LLC
10% Owner
Transactions
- Purchase
Class A Common Stock
2023-09-12$2.63/sh+90,000$236,520→ 49,665,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-11$2.34/sh+90,000$210,222→ 49,575,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-13$2.65/sh+90,000$238,221→ 49,755,442 total(indirect: See Footnote)
Transactions
- Purchase
Class A Common Stock
2023-09-12$2.63/sh+90,000$236,520→ 49,665,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-13$2.65/sh+90,000$238,221→ 49,755,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-11$2.34/sh+90,000$210,222→ 49,575,442 total(indirect: See Footnote)
CPF III PT SPV, LLC
10% Owner
Transactions
- Purchase
Class A Common Stock
2023-09-11$2.34/sh+90,000$210,222→ 49,575,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-12$2.63/sh+90,000$236,520→ 49,665,442 total(indirect: See Footnote) - Purchase
Class A Common Stock
2023-09-13$2.65/sh+90,000$238,221→ 49,755,442 total(indirect: See Footnote)
Footnotes (5)
- [F1]Includes (i) 69,433.68 shares of Common Stock directly acquired by CPF III PT SPV, LLC ("SPV III") and (ii) 20,566.32 shares of Common Stock directly acquired by CPF III PT SPV-A, LLC ("SPV-A III").
- [F2]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.
- [F3]Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III-A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III-A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.9366, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.
- [F5]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.84, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.
Issuer
P3 Health Partners Inc.
CIK 0001832511
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001975601
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:18 AM ET
- Size
- 15.8 KB